Cryoport’s (CYRX) Logistics Solution to Support Stemedica’s Ischemic-Tolerant … – StreetInsider.com
|
Cryoport’s (CYRX) Logistics Solution to Support Stemedica’s Ischemic-Tolerant …
StreetInsider.com Cryoport (NASDAQ: CYRX) announced that its validated cryogenic logistics solution is supporting the worldwide distribution of Stemedica’s ischemic-tolerant stem cell product lines. Stemedica Cell Technologies, Inc. (“Stemedica”) develops and … |
|
International Stem Cell Corporation Announces Record Net Income in Second …
CNNMoney International Stem Cell Corporation (OTCQB: ISCOD) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business … |
|
Global Stem Cell Research Market 2015 to 2017 by Market Research Store
Medgadget.com (blog) The leading business intelligence provider, has released its latest research Stem Cell Research Market to 2017 – Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D. The report provides an … Substrate Forges Pathway for Stem Cell FactoriesLabmate Online Global Stem Cell Research Market 2015 Forecast to 2017 by Market Research StoreDigital Journal |
USC News |
Local high school students graduate from USC’s summer stem cell program
USC News Since 2012, the program has enabled more than 50 students from local high schools to apply to work in USC Stem Cell labs and take hands-on courses at the USC Stem Cell Core Facility. This year’s students hailed from Cupertino High School, Fairfax High … |
USC News |
Local high school students graduate from USC’s summer stem cell program
USC News Since 2012, the program has enabled more than 50 students from local high schools to apply to work in USC Stem Cell labs and take hands-on courses at the USC Stem Cell Core Facility. This year’s students hailed from Cupertino High School, Fairfax High … |
Bloomberg |
Pivoting From Photos to Stem Cells, Fujifilm Finds a Second Life
Bloomberg Komori is no scientist, but the image embodies the Japanese brand’s shift away from photo-film and to new science and technology markets: Ebola drugs, anti-aging lotions and stem cell research. Over the last decade, Komori diversified into new … |